Lycia Therapeutics (LYCA): 10% owner bought ~$231K

~$231K

Approx. value · 8,804 sh @ $26.27

6.85M

Holds after · shares reported

Traded

Oct 30, 2026

Filed

Oct 30, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Oct 23, 2026Insider · 1 personInsiders: 2 purchases (~$1.4M)
2. Oct 26, 2026Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
3. Oct 26, 2026Insider · 1 personInsiders: 2 purchases (~$35.2M)
4. Oct 27, 2026Insider · 1 personInsiders: 2 purchases (~$1.1M)
5. Oct 28, 2026Insider · 1 personInsiders: 2 purchases (~$382K)
6. Oct 29, 2026Insider10% owner purchased ~$26K of LYCA shares in the open market
7. Oct 30, 2026 · this disclosureInsider10% owner purchased ~$231K of LYCA shares in the open market

What came next

1. Oct 30, 20265% stakeVenrock Healthcare Capital Partners III, L.P. reported a passive stake (13G) of 11.9%
2. Oct 30, 2026Insider10% owner purchased ~$5.4K of LYCA shares in the open market
3. Nov 2, 2026Insider10% owner purchased ~$224K of LYCA shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Lycia Therapeutics

For Lycia Therapeutics, OQRO holds 12 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LYCA page.

Other recent filings by Venrock Healthcare Capital Partners III, L.P., 10% owner

• SEC Form 4 at Lycia Therapeutics (LYCA)Nov 4, 2026
• SEC Form 4 at Lycia Therapeutics (LYCA)Oct 30, 2026
• SEC Form 4 at Lycia Therapeutics (LYCA)Oct 30, 2026
• SEC Form 4 at Lycia Therapeutics (LYCA)Oct 30, 2026
• SEC Form 4 at Lycia Therapeutics (LYCA)Oct 30, 2026

The full history of Venrock Healthcare Capital Partners III, L.P., 10% owner is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Lycia Therapeutics

• SEC Form 4Nov 4, 2026
• SEC Schedule 13GOct 30, 2026
• SEC Form 4Oct 30, 2026
• SEC Form 4Oct 30, 2026
• SEC Form 4Oct 30, 2026
• SEC Form 4Oct 30, 2026

Everything OQRO holds on this company is on its LYCA page.